Results of the first international quality control programme for oral targeted oncolytics.

Eline L GiraudLindsey M H Te BrakeErik C A van den HomberghIngrid M E DesarDina M KweekelNielka P van Erp

Published in: British journal of clinical pharmacology (2023)

Considering this is the first evaluation of an international QC programme for oral targeted oncolytics, an impressive high percentage of measurements were within the predefined range of accuracy. Cross-validation of assays that are used for dose optimization of oncolytics will secure the performance and will protect patients from incorrect advices.

Keyphrases

quality control
end stage renal disease
ejection fraction
newly diagnosed
cancer therapy
chronic kidney disease
study protocol
prognostic factors
peritoneal dialysis
drug delivery